1.
晚期NSCLC预后影响因素的单因素分析结果
Advanced NSCLC prognostic factors in univariate analysis
| Clinical factor | n (%) | Median survival time (month) | P |
| X: unknown. | |||
| Gender | < 0.001 | ||
| Male | 1, 132 (64.9) | 9 | |
| Female | 610 (35.1) | 13 | |
| Age (year) | 0.110 | ||
| < 65 | 969 (55.6) | 10 | |
| ≥ 65 | 773 (44.4) | 9 | |
| Smoking history | < 0.001 | ||
| No | 847 (48.6) | 13 | |
| Yes | 895(51.4) | 8 | |
| Gross type | < 0.001 | ||
| Central | 778 (44.7) | 8 | |
| Peripheral | 964 (55.3) | 11 | |
| Pathology | < 0.001 | ||
| Adenocarcinoma | 1, 086 (62.3) | 12 | |
| Squamous cell carcinoma | 305 (17.5) | 8 | |
| Adenosquamous | 68 (3.9) | 8 | |
| Indefinite | 280 (16.1) | 7 | |
| Large cell carcinoma | 3 (0.2) | 14 | |
| T stage | < 0.001 | ||
| 1 | 59 (3.4) | 15 | |
| 2 | 847 (48.6) | 10 | |
| 3 | 159(9.1) | 8 | |
| 4 | 643 (36.9) | 10 | |
| X | 34(2.0) | ||
| N stage | < 0.001 | ||
| 0 | 136 (7.8) | 14 | |
| 1 | 168 (9.6) | 13 | |
| 2 | 782 (44.9) | 10 | |
| 3 | 568 (32.6) | 9 | |
| X | 88 (5.0) | ||
| Number of organs with metastasis | < 0.001 | ||
| 1 | 1, 246 (71.5) | 11 | |
| > 1 | 496 (28.5) | 7 | |
| Chemotherapy | < 0.001 | ||
| No | 491 (28.2) | 6 | |
| Yes | 1, 251 (71.8) | 11 | |
| Cycle | < 0.001 | ||
| 0 | 491 (28.2) | 6 | |
| ≤ 4 | 882 (50.6) | 9 | |
| > 4 | 369(21.2) | 23 | |
| Radiotherapy | 0.017 | ||
| Yes | 422 (24.2) | 11 | |
| No | 1, 320 (75.8) | 9 | |